Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Marler

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Stroke|April 1, 1989
Morning increase in onset of ischemic strokeJ R Marler, T R Price, G L Clark, et al.
Stroke|October 7, 2000
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trialJ P Broderick, M Lu, R Kothari, et al.
The New England Journal of Medicine|June 11, 1999
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study GroupT G Kwiatkowski, R B Libman, M Frankel, et al.
Annals of Neurology|June 21, 2001
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic strokeJ Broderick, M Lu, C Jackson, et al.
Neurology|May 5, 1998
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study GroupS C Fagan, L B Morgenstern, A Petitta, et al.
JAMA|June 24, 2000
Recommendations for the establishment of primary stroke centers. Brain Attack CoalitionM J Alberts, G Hademenos, R E Latchaw, et al.
Neurology|December 13, 2000
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke studyJ R Marler, B C Tilley, M Lu, et al.
JAMA|December 12, 2001
Lack of clinical significance of early ischemic changes on computed tomography in acute strokeS C Patel, S R Levine, B C Tilley, et al.
Stroke|August 19, 2006
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standardsVladimir Hachinski, Costantino Iadecola, Ron C Petersen, et al.
Stroke|August 6, 1999
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapyJ C Grotta, D Chiu, M Lu, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Stroke|April 1, 1989
Morning increase in onset of ischemic strokeJ R Marler, T R Price, G L Clark, et al.
Stroke|October 7, 2000
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trialJ P Broderick, M Lu, R Kothari, et al.
The New England Journal of Medicine|June 11, 1999
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study GroupT G Kwiatkowski, R B Libman, M Frankel, et al.
Annals of Neurology|June 21, 2001
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic strokeJ Broderick, M Lu, C Jackson, et al.
Neurology|May 5, 1998
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study GroupS C Fagan, L B Morgenstern, A Petitta, et al.
JAMA|June 24, 2000
Recommendations for the establishment of primary stroke centers. Brain Attack CoalitionM J Alberts, G Hademenos, R E Latchaw, et al.
Neurology|December 13, 2000
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke studyJ R Marler, B C Tilley, M Lu, et al.
JAMA|December 12, 2001
Lack of clinical significance of early ischemic changes on computed tomography in acute strokeS C Patel, S R Levine, B C Tilley, et al.
Stroke|August 19, 2006
National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standardsVladimir Hachinski, Costantino Iadecola, Ron C Petersen, et al.
Stroke|August 6, 1999
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapyJ C Grotta, D Chiu, M Lu, et al.
Pageof 7